Pimavanserin: A Solution for Psychosis in Parkinson's Disease?

Psychopharmacology and Psychiatry Updates

English - November 23, 2023 17:00 - 8 minutes - 12.1 MB - ★★★★★ - 232 ratings
Medicine Health & Fitness Science mentalhealth psychiatry psychopharmacology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Current Approaches to Treating Pediatric Bipolar Disorder

Next Episode: Understanding Sleep-Related Eating Disorder (SRED)

This episode explores the controversial role of pimavanserin in treating psychosis in Parkinson's disease. How does it compare with quetiapine or clozapine? Sneak peek: All of these medications are effective, yet none distinctly surpasses the others.

Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.

Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 51 Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis